Neogen | NEOG - Selling And Administration Expenses

Stock Price
9.09
Daily Change
-0.26 -2.78%
Monthly
-17.29%
Yearly
0.44%
Q1 Forecast
8.82

Neogen reported $107.5M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Cerus USD 19.33M 1.55M Dec/2024
Danaher USD 2.03B 35M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Illumina USD 283M 27M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Pacific Biosciences Of California USD 43.75M 2.13M Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.94M 20.44M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Utah Medical Products USD 1.87M 50K Sep/2024
Zoetis USD 619M 40M Dec/2025